MedPath

Human Bone Graft in Epiphysiodesis

Recruiting
Conditions
Leg Length Differences
Primordial Gigantism
Interventions
Procedure: epiphysiodesis
Registration Number
NCT04067895
Lead Sponsor
Medical University of Vienna
Brief Summary

This observational study is to document the application of human bone graft in the surgical treatment (epiphysiodesis) of leg length discrepancy or primordial gigantism and its subsequent healing process.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Planned epiphysiodesis to stop the growing of a bone indicated by leg length discrepancies or primordial gigantism
  • Age 10-18 years
  • Written consent to participate in the study after previous written and oral education (additional consent for the participation of minors in the study after prior written and oral education by at least one parent)
Read More
Exclusion Criteria
  • Insufficient knowledge of the german language
  • Foreseeable compliance issues
  • Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
  • Patients with non-treated pre-existing conditions, which could be the cause of leg length differences
  • Active osteomyelitis
  • Ulcerations in the area of the skin of the surgical area
  • Immunosuppressive drugs that can not be discontinued
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
human bone graft screwepiphysiodesishuman bone graft screws will be used during the epiphysiodesis
Primary Outcome Measures
NameTimeMethod
formation of a bone bridge1 year

based on x-rays or MRI: Is as formation of a bone bridge visible? YES/NO How many millimeters? mm

sclerosing around the screw1 year

based on x-rays or MRI: Is a sclerosis around the screw visible? YES/NO

incidence of surgical revisions1 year

Was a surgical revision done postoperatively? YES/NO

incidence of a dislocation of the screw1 year

based on x-rays or MRI: Is the screw dislocated? YES/NO

cystic brightening around the screw1 year

based on x-rays or MRI: Is a cystic brightening around the screw visible? YES/NO

incidence of additional surgery1 year

Was an additional surgery necessary to stop growth? YES/NO; Which one?

incidence of cracking of the screw1 year

based on x-rays or MRI: Is a crack of the screw visible? YES/NO

incidence of postoperative inflammatory complications1 year

Is a postoperative inflammatory complication recognizable? YES/NO

evaluation of postoperative pain (VAS)1 year

The visual analogue scale (VAS) is a vertical line, 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extremes (0mm = no pain - 100mm = worst imaginable pain). A higher score indicates more pain.

Secondary Outcome Measures
NameTimeMethod
evaluation of wound healing disorder1 year

Is a disorder of the wound healing recognizable? NO/MILD/MODERATE/SEVERE

evaluation of swelling1 year

Is a swelling in the surgery area visible? NO/MILD/MODERATE/SEVERE

Knee Outcome Survey - Activities of Daily Living Scale (KOS-ADL)1 year

The KOS ADL score includes 14 questions and is divided in 2 subscales, symptoms (6 items, max. score 30) and functional restrictions (8 items, max. score 40). The scores of the answers range from 0 to 5 points. 0 points mean no impairment of everyday activities, while 5 points represent the greatest possible impairment. All points are summed up.

From this, the KOS-ADL score is calculated as the proportion of the total response points from the possible maximum score (70) in percent. KOS ADL Score \[%\] = ( symptoms pts. + functional restrictions pts.)\*100/70. The percentage ranges from 0-100%. 0% means no impairment, while 100% represents the greatest possible impairment.

evaluation of hematoma1 year

Is a hematoma in the surgery area visible? NO/MILD/MODERATE/SEVERE

International Knee Documentation Committee Subjective Knee Form (IKDC Score)1 year

The IKDC Score contains 19 questions (7 questions for symptomatology, 10 concerning function, 2 about sport activity). The lowest function level or the highest symptom level receives the score value 1. The highest function level or the lowest symptom level is given the number n according to the number n of possible answers. With the exception of question 10 "Functioning before knee injury", the remaining 18 response points are summed up. This gives the "raw sum". The lowest possible score is 18 and the maximum possible score is 87. The raw sum is converted into a scale of 0 to 100 using the following formula: ((raw score - lowest possible score)/score range)\*100. 0 points mean the greatest possible impairment, while 100 points mean complete freedom from symptoms and functioning. The IKDC score can only be calculated if at least 16 of the 18 questions have been answered.

patient satisfaction (VAS)1 year

The visual analogue scale (VAS) is a vertical line, 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extremes (0mm = very satisfied - 100mm = not satisfied at all). A higher score indicates less satisfaction.

Revised questionnaire to assess Health-Related Quality of Life in children and adolescents (KINDL)1 year

The KINDL is a generic instrument for assessing Health-Related Quality of Life in children and adolescents aged 3 years and older. There are 3 versions available for different age groups: Kiddy-KINDL 4-6 years, Kid-KINDL 7-13 years, Kiddo-KINDL 14-17 years. The questionnaires used in this study (Kid-KINDL and Kiddo-KINDL) provide 24 Likert-scaled items associated with 6 dimensions: physical well-being ,emotional well-being, self-esteem, family, friends, and school. All versions also contain an additional section 'disease' with 6 items. They can be completed in case of illness or hospitalization. The items and sub-scales are calculated according to the KINDL manual and a higher score corresponds to a higher health-related quality of life.

Trial Locations

Locations (1)

General Hospital Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath